Metallocenes, labelled with 103 Ru, are potential radiopharmaceuticals for use in nuclear medicine diagnosis. Ruthenocene derivatives with oxopropene side-chains were administered to mice and rats to study their biochemical properties. Excretion rates and organ distributions of 103 RuCl 3 and Cinnamoyl-[ 103 Ru] ruthenocene were very different. While 103 RuCl 3 was relatively evenly distributed in the body, the metallocene derivative was concentrated in liver, lungs and spleen after intravenous (i.v.) injection. After i.p. injection however a high thymus affinity was observed and autoradiography proved that the site of 103 Ru accumulation was in thymocytes. The thymus affinity can be diminished by corticoid pretreatment and raised by inhibition of phagocytosis (BeSO 4 ). The mechanism of accumulation in the thymus and a possible clinical application are discussed.
Contents
-
June 2, 2014
-
June 2, 2014
-
June 2, 2014
-
June 2, 2014
-
June 2, 2014
-
Open AccessConformations of the Nucleoside Analogs Formycin, 2-Azaadenosine, and Nebularine in SolutionJune 2, 2014
-
June 2, 2014
-
June 2, 2014
-
June 2, 2014
-
June 2, 2014
-
June 2, 2014